Wednesday, December 13, 2017 7:38:14 AM
Eqova.com they are a are Clinical-grade CBD products exclusive for doctors for doctors.
Authorized Shares 500,000,000 a/o Nov 07, 2017
Outstanding Shares 141,143,444 a/o Nov 07, 2017
Float 133,823,444 a/o Nov 07, 2017
CEO video
37% insider ownership !
https://www.otcmarkets.com/financialReportViewer?symbol=GRCK&id=181626
Large insider ownership usually means they will want a substantial increase in the pps.
Article on acquisition (Uncompensated)
http://psinvestor.com/grey-cloak-delivers-eqova-acquision-with-solid-structure-sets-stage-for-rebound/
Another article
https://www.networknewswire.com/strategic-acquisition-enables-grey-cloak-tech-inc-s-grck-development-two-industries/
Recently Uplisted to OTCQB, Audited
Cancelled RS replaced with increased AS
Form 14PRE: https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12360234.
The highlights:
• According to The Hemp Business Journal, CBD products marketplace are projected to grow by 700% by 2020 with annual sales reaching $2.1 billion.
•Eqova's CEO, Patrick Stiles, is personally responsible for founding and growing more than one nutraceutical brand. His brands have sold millions of dollars in products online through a variety of channels.
Upcoming Catalysts
– Sales projections?– Significant Sales?– Regional distributors?– Roll Out New Products
Anticipating launch of CBD.co by EOY 2017.
The posts contained on this account are my own opinions and are not recommendations or advise to buy or sell any security, stocks or other investments. These posts are for entertainment purposes only and are not considered to be facts or truth.
Recent HYEX News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:22:30 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/24/2023 06:25:27 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 10/06/2023 06:09:39 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/14/2023 05:22:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 06:30:40 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/05/2023 08:24:27 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/24/2023 08:12:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:09:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2023 05:30:59 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM